Clinical Trials
5 trialsNCT00006022 2015-12-14
Interleukin-2 Plus Bryostatin 1 in Treating Patients With Melanoma or Kidney Cancer
Virginia Commonwealth University
Phase 1 Completed
NCT00005056 2013-06-26
Bryostatin 1 In Treating Patients With Progressive Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00112476 2013-05-03
Temsirolimus and Bryostatin 1 in Treating Patients With Unresectable or Metastatic Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00003968 2013-02-08
Bryostatin 1 in Treating Patients With Metastatic Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00032188 2013-01-24
Interleukin-2 and Bryostatin 1 in Treating Patients With Advanced Kidney Cancer
National Cancer Institute (NCI)
Phase 2 Completed